Compare STE & BCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STE | BCH |
|---|---|---|
| Founded | 1985 | 1893 |
| Country | United States | Chile |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.5B | 20.8B |
| IPO Year | 1992 | 2002 |
| Metric | STE | BCH |
|---|---|---|
| Price | $268.33 | $40.08 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 2 |
| Target Price | ★ $268.25 | $29.50 |
| AVG Volume (30 Days) | ★ 489.5K | 230.2K |
| Earning Date | 02-04-2026 | 01-15-2026 |
| Dividend Yield | 0.94% | ★ 3.91% |
| EPS Growth | ★ 59.39 | N/A |
| EPS | ★ 6.97 | 0.01 |
| Revenue | ★ $5,702,415,000.00 | $2,935,400,013.00 |
| Revenue This Year | $9.61 | $26.08 |
| Revenue Next Year | $6.23 | $6.51 |
| P/E Ratio | $38.48 | ★ $15.06 |
| Revenue Growth | ★ 7.08 | N/A |
| 52 Week Low | $204.90 | $23.11 |
| 52 Week High | $269.44 | $41.37 |
| Indicator | STE | BCH |
|---|---|---|
| Relative Strength Index (RSI) | 65.54 | 58.63 |
| Support Level | $256.51 | $40.45 |
| Resistance Level | $263.08 | $41.32 |
| Average True Range (ATR) | 5.55 | 0.79 |
| MACD | 1.33 | 0.04 |
| Stochastic Oscillator | 95.17 | 65.41 |
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
Operating under three separate brand names (Banco de Chile, Banco Edwards-Citi, and Banco CrediChile), Banco de Chile is the second largest in the country by loans and third largest by deposits. Banco de Chile generates most of its net interest income (roughly 60% of total revenue) from its mortgage, unsecured consumer credit lines, and commercial loans, with 25% of its outstanding loans being made to firms with more than 10,000 million CLP in revenue. Outside of its banking business, Banco de Chile is the largest asset manager in the country and one of the largest security brokerages, supporting its substantial fee-based revenue.